Browse: Home / Milan District Court Confirms the Validity of Alfa Wassermann’s Rifaximin-alpha Patents

Menu

Skip to content
  • Home
  • About Us
  • Contact Us
  • Submit News
Header image

Cambodian TribuneLogo

Latest Cambodian News

Menu

Skip to content
  • Misc
  • Affairs
  • Information
  • Fashion
  • Self Care
  • Athletic
  • Domestic Affairs
  • Legal
  • PRESS RELEASES
  • UN to Host Human Rights Day Celebration in Cambodia This Weekend
  • Cambodia, the U.S., Optimistic about Bilateral Relations in Labour Sector
  • Japan Travel Fair to Be Held This Weekend
  • Cambodia Encourages Investment in New Technology
  • AIMF Secretary General Surprised of Phnom Penh's Progress

Milan District Court Confirms the Validity of Alfa Wassermann’s Rifaximin-alpha Patents

Posted by admin on June 12, 2014 in Legal | 14 Views

BOLOGNA, Italy, June 12, 2014 /PRNewswire/ —

Normix® is the only authorized Gastrointestinal antibiotic based on Rifaximin-alpha. No generic version is allowed.

With the judgment entered last April 18, the district court of Milan, Italy – the court having original jurisdiction on the matter -denied a request from generic manufacturers to declare Alfa Wassermann’s patents on Rifaximin polymorphs invalid. Instead, the court upheld Alfa Wassermann’s claim, asserting the Rifaximin-alpha patent and prohibiting any further counterfeit production, advertising and marketing. The announcement is made by Alfa Wassermann, the Bologna-based Italian pharmaceutical multinational that developed Rifaximin-alpha, marketed under the trade name Normix® in Italy, Xifaxan®, Flonorm®, Rifacol®, Spiraxin® and other trade names in other countries. Approved in 34 countries including the US, Rifaximin-alpha is an oral gut-selective antibiotic indicated for most bacterial diarrheas, including travelers’ diarrhea, and other gastrointestinal (GI) disorders. Recently, Rifaximin-alpha was also approved for Hepatic Encephalopathy (HE) in the US and in Europe.

(Logo: http://photos.prnewswire.com/prnh/20140612/690926 )

"We welcome the court decision that has confirmed the uniqueness of Rifaximin-alpha, which is Alfa Wassermann R&D’s most prestigious product and one of the top selling Italian medicines in the US," said Andrea Golinelli, Chief Strategy Officer, Alfa Wassermann. "The court ruling is a landmark decision for the protection of intellectual property (IP) and the recognition of its crucial value for pharmaceutical R&D and innovation. Without IP protection no scientific innovation nor progress to improve people’s health is possible." concluded Golinelli.

Alfa Wassermann

Alfa Wassermann is an international Italian pharmaceutical Group with a sixty-year tradition in R&D, production and distribution of medicines of primary importance for people’s health. Its medicines have taken Alfa Wassermann to a leading position in a number of medical areas including Gastroenterology, Vascular medicine, Orthopedics, Rheumatology and Gynecology.

The Group is headquartered in Bologna, Italy, which is also the location of its long-standing R&D facilities. The Group’s international division is in Milan. The Group’s production facilities in Alanno (Pescara, Italy) are some of Europe’s most technologically advanced and make 50 million packaged items annually.

Alfa Wassermann operates globally through 12 subsidiaries in as many world markets. The Group employs 1,400 people and markets products in over 60 countries. In 2013 Alfa Wassermann consolidated sales aggregated to some 400 million euro.

Alfa Wassermann R&D’s most successful product is Rifaximin-alpha, an oral antibiotic for gastrointestinal disorders that is the market leader in Italy, but is also available in many other world countries, including the US. Rifaximin-alpha approval by the US Food and Drug Administration (FDA) has been a highly prestigious recognition for a medicine that is the fruit of Italian R&D.

For further information please visit http://www.alfawassermann.com

Media contact:
Angela Del Giudice
+39-06-6788870
a.delgiudice@vrelations.it

Posted in Legal | Tagged HEA, LAW, MTC, PHA, PLW

Related Posts

Missing imageDKSH Supports Growth for Vitabiotics in Hong Kong and Malaysia→

Missing imageSphenopalatine Ganglion Stimulation in the Pathway CH-1 Study Reduces Headache Burden Before and After Sustained Periods of Cluster Attack Remission→

Missing imageLatin American Contract Research Organizations Set to Get More Local Outsourcing Opportunities→

Missing imageDPM Tea Banh: ADMM Retreat, ADMM-Plus Focus on Regional Peace and Stability→

Search

Pages

  • Home
  • About Us
  • Contact Us
  • Submit News

Categories

Calendar

December 2019
M T W T F S S
« Nov    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Advertisement

Latest News

  • Missing image

    UN to Host Human Rights Day Celebration in Cambodia This Weekend

    December 5, 2019 / admin
  • Missing image

    Cambodia, the U.S., Optimistic about Bilateral Relations in Labour Sector

    December 5, 2019 / admin
  • Missing image

    Japan Travel Fair to Be Held This Weekend

    December 5, 2019 / admin
  • Missing image

    Cambodia Encourages Investment in New Technology

    December 5, 2019 / admin
  • Missing image

    AIMF Secretary General Surprised of Phnom Penh’s Progress

    December 4, 2019 / admin
  • Missing image

    Ministry of Environment: More Action Should Be Taken Against Plastic Waste

    December 4, 2019 / admin
  • Missing image

    New Swedish Ambassador Pays Courtesy Call on Cambodian PM

    December 4, 2019 / admin
  • Missing image

    Cambodian DPM Wants AIMF to Be a Multilateral Mechanism

    December 4, 2019 / admin
  • Missing image

    39th AIMF General Assembly Officially Kicks Off

    December 4, 2019 / admin
  • Missing image

    PM Hun Sen Congratulates Cambodian U22 Football Team

    December 4, 2019 / admin
  • Facebook
  • Pinterest
  • Tumblr
  • Twitter

Pages

  • About Us
  • Contact Us
  • Submit News

Categories

 

Recent Posts

  • UN to Host Human Rights Day Celebration in Cambodia This Weekend December 5, 2019
  • Cambodia, the U.S., Optimistic about Bilateral Relations in Labour Sector December 5, 2019
  • Japan Travel Fair to Be Held This Weekend December 5, 2019
 

Search

Archives

 

About Us

Cambodia Tribune is a website which acts as an information bank in which news and press releases from various sources are updated on a regular basis. The information is associated with Cambodia and features national news, business news, technological news and other news coverage.
 

©2019 Cambodian Tribune

Menu

  • Home
  • About Us
  • Contact Us
  • Submit News